Rising Global Cancer Burden Exposes Gaps in Cancer Prevention, Care

The International Agency for Research on Cancer (IARC) has revealed that the global cancer burden is escalating, with an estimated 20.6 million new cancer cases and 9.8 million cancer-related deaths occurring in 2024. This data, released through the Global Cancer Observatory, indicates that one in five individuals worldwide will likely develop cancer in their lifetime.

Without substantial advancements in prevention and treatment, the number of annual new cases is expected to surge to 34 million by 2050, while cancer deaths could reach 17.5 million. IARC's Head of the Cancer Surveillance Branch, Freddie Bray, emphasized the urgency of the situation, stating that disparities in cancer death rates between men and women, as well as significant geographical variations, underscore the need for immediate action.

China accounts for nearly one in four global cancer cases and cases resulting in death, while Europe contributes more than one-fifth of the worldwide cancer incidence despite housing only 9.2 percent of the global population. Cancer incidence and mortality rates vary widely between countries, with the highest incidence rates observed in nations like Australia and Denmark, and the lowest in certain regions of sub-Saharan Africa.

Mortality rates are notably elevated in Eastern Europe and Melanesia due to specific cancers, such as liver cancer in Mongolia and cervical cancer in Zimbabwe. The leading causes of both cancer incidence and mortality are lung cancer and breast cancer, respectively. Breast cancer is the most frequently diagnosed cancer among women in 164 countries, and it is the primary cause of cancer death in 122 countries.

In sub-Saharan Africa, breast and cervical cancers are responsible for over half of the cancer cases affecting women. IARC warns that unless there is a two percent annual decline in cancer incidence and mortality, the current statistics are unlikely to improve. The agency attributes the persistent rise in cancer cases to aging populations, tobacco use, and existing inequities in cancer control measures.

Addressing these challenges necessitates bolstering cancer surveillance systems, expanding prevention and screening initiatives, enhancing early diagnosis, and guaranteeing equitable access to effective treatment.